Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2021

May 13, 2021

33728_dirs_2021-05-13_f8c61507-9d60-46a4-b9ae-cf84b28d781b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-04-30

Reporting Person: Chiruvolu Vijay (Chief Technical Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-30 Employee Stock Option (right to buy) $20.53 A 154237 Acquired 2031-04-29 Common Stock (154237.0) Direct
2021-05-11 Employee Stock Option (right to buy) $16.25 A 200000 Acquired 2031-05-10 Common Stock (200000.0) Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vest on April 30, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

F2: The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date.